CAS: 88699-91-6 - (δE)-δ-[(2-Aminoethoxy)imino]-4-(trifluoromethyl)benzenepentanoic acid
Formula:C14H17F3N2O3
InChI:InChI=1S/C14H17F3N2O3/c15-14(16,17)11-6-4-10(5-7-11)12(19-22-9-8-18)2-1-3-13(20)21/h4-7H,1-3,8-9,18H2,(H,20,21)/b19-12+
InChI key:InChIKey=KUIZEDQDELAFQK-XDHOZWIPSA-N
SMILES:O=C(O)CCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
- Synonyms:
- Benzenepentanoic acid, δ-[(2-aminoethoxy)imino]-4-(trifluoromethyl)-, (δE)-
- Benzenepentanoic acid, δ-[(2-aminoethoxy)imino]-4-(trifluoromethyl)-, (E)-
- (δE)-δ-[(2-Aminoethoxy)imino]-4-(trifluoromethyl)benzenepentanoic acid
Ref: 4Z-F-181
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Fluvoxamine Impurity 1
CAS:88699-91-6
Formula:
C19H23F3N2O5
Color and Shape:
White To Off-White Solid
Molecular weight:
416.40
Ref: 4Z-F-1816
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Fluvoxamine Acid
Controlled ProductCAS:88699-91-6
Applications The major metabolite of Fluvoxamine. References Overmars, H., et al.: Eur. J. Drug Metab. …
Formula:
C14H17F3N2O3
Color and Shape:
Neat
Molecular weight:
318.29
Ref: TR-F603490
1mg | 335.00 € | ||
5mg | 1,363.00 € | ||
10mg | 2,164.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
Fluvoxamine acid
CAS:88699-91-6
Fluvoxamine acid is a serotonin reuptake inhibitor that is used to treat depression. It is …
Formula:
C14H17F3N2O3
Purity:
Min. 95%
Molecular weight:
318.29 g/mol
Ref: 3D-FF23524
1mg | 683.00 € | ||
5mg | 2,083.00 € | ||
10mg | 3,675.00 € |
Estimated delivery in United States, on Friday 28 Mar 2025
Fluvoxamine Acid Trifluoroacetic Acid Salt
CAS:88699-91-6
Applications Fluvoxamine Acid Trifluoroacetic Acid Salt is the major metabolite of Fluvoxamine (F603500). References Overmars, …
Formula:
C16H18F6N2O5
Color and Shape:
Neat
Molecular weight:
472.42
Ref: TR-F603495
5mg | Discontinued | Request information | |
50mg | Discontinued | Request information |